Open AccessS744 Risankizumab Induction Therapy Provides Early Symptom Improvements in Abdominal Pain and Stool Frequency in Patients With Moderate to Severe Crohn’s Disease: Results From Two Phase 3 Induction Studies
Author(s) -
Jean–Frédéric Colombel,
Stefan Schreiber,
Geert R. D’Haens,
Joanne Rizzo,
Kristina Kligys,
Jenny Griffith,
Javier Zambrano,
Qian Zhou,
Jasmina Kalabic,
Florian Rieder,
Marla Dubinsky,
Remo Panaccione
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000776508.24654.5b
Subject(s) - medicine , placebo , crohn's disease , abdominal pain , gastroenterology , clinical trial , quality of life (healthcare) , randomized controlled trial , disease , pathology , alternative medicine , nursing